The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
2006 ◽
Vol 103
(25)
◽
pp. 9643-9648
◽
Keyword(s):
2011 ◽
Vol 40
(4)
◽
pp. 1133-1141
◽
2018 ◽
Vol 366
(2)
◽
pp. 390-396
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 63
(5)
◽
pp. 2372-2390
◽
Keyword(s):
2019 ◽
Vol 847
◽
pp. 83-90
◽